Healthcare / Medical Care FacilitiesTaipei Exchange
$21.85
-0.90 (-3.96%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $213.8M · quality 42.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
16/100
F
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$983M
P/E
N/A
•EV/EBITDA
8.9x
↓ROE
-15.2%
↓Gross Margin
12.7%
↓Debt/Equity
1.55
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+1.1%
FCF CAGR
+69.4%
FCF margin
19.6%
FCF / Net income
-3.19x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.09B · net income $-67.1M · FCF $213.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.09B | $1.09B | $1.13B | $1.22B | $1.06B |
| Net Income | $-67.1M | $-67.1M | $10.3M | $-42.5M | $-30.9M |
| EBITDA | $173.5M | $173.5M | $271.1M | $207.8M | $158.5M |
| EPS | — | — | 0.24 | -1.00 | -0.73 |
| Gross Margin | 12.7% | 12.7% | 13.3% | 14.1% | 15.2% |
| Operating Margin | -0.4% | -0.4% | 0.8% | 2.1% | 3.2% |
| Net Margin | -6.1% | -6.1% | 0.9% | -3.5% | -2.9% |
| Balance Sheet | |||||
| Debt/Equity | 1.55 | 1.55 | 1.55 | 2.16 | 1.93 |
| Current Ratio | 0.50 | 0.50 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $213.8M | $213.8M | $313.5M | $151.7M | $44.0M |
| Returns | |||||
| ROE | -15.2% | -15.2% | 2.2% | -10.4% | -7.2% |
| Valuation | |||||
| P/E | — | — | 133.33 | — | — |
| EV/EBITDA | 8.90 | 8.90 | 7.37 | 10.97 | 15.79 |
| P/B | 2.23 | 2.23 | 2.97 | 3.65 | 4.10 |
| Growth & Yield | |||||
| Revenue Growth | -3.3% | -3.3% | -7.2% | 15.1% | — |
| EPS Growth | — | — | 124.0% | -37.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-23.2%
Start / end P/E
n/dx → n/dx
EPS bridge
0.24 → n/d
Residual
-23.2%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.